Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Actinium Pharmaceuticals, Inc. (ATNM) had Return on Investments of -36.17% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.88M |
|
-- |
|
-- |
|
$7.50M |
|
$-7.50M |
|
$0.62M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-6.88M |
|
$-7.50M |
|
$-7.30M |
|
31.20M |
|
31.20M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$61.03M |
|
$0.27M |
|
$1.99M |
|
$63.02M |
|
$8.31M |
|
$0.01M |
|
$35.69M |
|
$44.00M |
|
$19.01M |
|
$19.01M |
|
$19.01M |
|
31.20M |
|
| Cash Flow Statement Financials | |
$-12.97M |
|
-- |
|
$-0.01M |
|
$73.23M |
|
$60.26M |
|
$-12.97M |
|
$9.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.34 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.18% |
|
-36.18% |
|
-10.91% |
|
|
Return on Investments |
-36.17% |
$0.61 |
|
$-0.42 |
|
$-0.42 |
|